Is Diversified Healthcare Trust overvalued or undervalued?
As of March 1, 2023, Diversified Healthcare Trust's valuation has shifted from very attractive to risky due to being overvalued with a negative P/E ratio and unsustainable dividend yield, despite strong recent stock performance.
As of 1 March 2023, the valuation grade for Diversified Healthcare Trust has moved from very attractive to risky. The company is currently overvalued given its financial metrics, particularly with a price to book value of 0.42 and an EV to EBITDA ratio of 2.14, which indicates a significant discrepancy compared to its peers. The negative P/E ratio reflects its loss-making status, while the dividend yield of 117.62% appears unsustainable given the company's ROCE of -2.76% and ROE of -8.93%.In comparison to its peers, Diversified Healthcare Trust's valuation is starkly lower than that of Gladstone Commercial Corp., which has a P/E ratio of 21.36 and an EV to EBITDA of 5.94, and TPG RE Finance Trust, with a P/E of 9.06 and an EV to EBITDA of 0.93. The company has shown strong stock performance recently, with a year-to-date return of 60.00%, significantly outperforming the S&P 500's 2.44% return, but this does not mitigate the overall valuation concerns.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
